Silver Producers Explode When Prices Run. This One Is Potentially Next
At Los Gatos, silver grades run over 200 g/t with costs near $15/oz. With silver at $41, margins are expanding fast.
Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients
Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple myeloma patients.
Skye Bioscience Advances Position In Competitive Obesity Market With Promising Data
Skye Bioscience's latest data show nimacimab boosted tirzepatide's weight loss effects and reduced obesity treatment rebound risk.
We've Seen This Before... and It Didn't End Well - Ad
Strange events are unfolding in the global financial system. A monetary reset dubbed the "Mar-a-Lago Accord" is quietly in motion, and the financial elite are already taking protective action. If history is any guide, you could lose up to 40% of your wealth in the next two years. Move your money before it's too late.
FDA proposes ban on Orange B, a food dye not used for decades
Federal regulators are proposing to remove another from the U.S. food supply — Orange B, a synthetic color that hasn't been used in the U.S. for decades.
UN report cites huge government corruption in South Sudan as its food crisis worsens
NAIROBI, Kenya (AP) — Billions of dollars in public funds in South Sudan have been stolen over the past decade in massive government corruption while the vast majority of the country suffers food insecurity, a U.N. commission said Tuesday.
Discover 3 Stocks Projected to Dethrone Nvidia (NVDA) - Ad
Futurist and Stock Analyst, Eric Fry, published a brand-new research report naming three outsider stocks have the power to completely disrupt the "seemingly invincible" Mag 7. For the time being, this research report is available through this page - at no charge.
Harmony Biosciences' Genetic Disorder Drug Disappoints In Phase 3 Study
Harmony Biosciences' ZYN002 failed to meet its primary goal in a Fragile X Phase 3 trial, but the company points to pipeline growth.
Al Gore's satellite and AI system is now tracking sources of deadly soot pollution
NEW YORK (AP) — Soon people will be able to use satellite technology and artificial intelligence to track dangerous soot pollution in their neighborhoods — and where it comes from — in a way not so different from monitoring approaching storms under plans by a nonprofit coalition led by former Vice President Al Gore.
The First Public Cash-Flowing Digital Treasury - Ad
Unlike Bitcoin vaults, this NASDAQ-listed company earns yield through BNB staking and nodes. $368M already deployed, still overlooked.
Trump cancels White House meeting with Schumer and Jeffries despite risk of a government shutdown
WASHINGTON (AP) — has abruptly canceled with congressional Democratic leaders, refusing to negotiate over their demands to shore up health care funds as part of a deal to prevent a potential looming .
More shrimp sold at Kroger stores recalled for possible radioactive contamination
A Seattle seafood distributor more cooked and frozen shrimp sold at Kroger grocery stores across the U.S. because of ongoing concerns about potential radioactive contamination.
Digital Gold. Digital Oil. Digital Infrastructure. - Ad
Bitcoin and Ethereum had their turn. Now a NASDAQ-listed firm is scaling BNB, which fuels 290M users and pays yield.
Pfizer Reportedly Nears Metsera Acquisition Deal: PFE Stock Climbs In Monday Pre-Market
Pfizer Inc. (NYSE: PFE) stock climbed 1.87% in Monday pre-market amid reports that the company on the verge of acquiring Metsera Inc. (NASDAQ: MTSR), a developer of anti-obesity drugs.
A robot programmed to act like a 7-year-old girl works to combat fear and loneliness in hospitals
Days after Meagan Brazil-Sheehan’s 6-year-old son was diagnosed with leukemia, they were walking down the halls of UMass Memorial Children’s Medical Center when they ran into Robin the Robot.
Could You Use Some Instant Cash Upfront? - Ad
Millionaire trader Jeff Clark's #1 income strategy gives you the chance to collect instant cash payouts, as much as $100 to $1,000 upfront! The great part is you can collect these upfront cash payouts without owning a single stock.... Jeff's put all the details in a special briefing titled Infinite Income Manifesto.
When self-doubt creeps in at work, pause and reframe your negative thoughts. Here's how
NEW YORK (AP) — When we make mistakes at work, it can lead to a cycle of negative thinking.
Hims & Hers Scrutinized For Marketing Its Product As Similar To Ozempic, Wegovy
FDA warns Hims & Hers that its semaglutide products are misbranded due to misleading claims and asks for corrective steps within 15 days.
Silver Producers Explode When Prices Run. This One Is Potentially Next - Ad
At Los Gatos, silver grades run over 200 g/t with costs near $15/oz. With silver at $41, margins are expanding fast.
Here's Novo Nordisk's First Oral Obesity Drug In Europe With Proven Heart Health Impact
EMA approved Rybelsus' label update after the SOUL trial showed it cuts heart attack, stroke, and death by 14% in high-risk type 2 diabetes patients.
Hims & Hers Faces FDA Heat As Commissioner Martin Makary Calls Out Super Bowl Ad For Hiding Drug Risks
FDA Commissioner Martin Makary said Hims & Hers broke federal law with its Super Bowl ad promoting weight-loss drugs without disclosing side effects, and called it "the most overt breach" of FDA rules.
The Next Evolution in Public Treasuries - Ad
MicroStrategy proved the model with BTC. Now a NASDAQ-listed firm is running it with BNB, yield, and 290M users. $368M locked in.
Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs to sharpen focus, meet competition
FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company's focus on growth opportunities in obesity and diabetes medications.
PTC Therapeutics Could Challenge BioMarin For Metabolic Disorder Treatment
BioMarin's Palynziq significantly lowered blood phenylalanine in teens with PKU, with nearly half reaching target levels in the Phase 3 study.
Jeff Brown: "I Warned You About Elon Musk..." - Ad
While everyone said Tesla was finished... On June 11, I predicted that we were on the cusp of one of the most shocking comebacks in Wall Street history. Sure enough, Tesla is now up 25% and recovered all 2025 losses. But this is just the beginning of Elon's $25 trillion breakthrough.
Trump Admin Targets Medicaid Spending On Immigrants, Threatening Over $12 Billion California Program
The Trump administration is investigating Medicaid spending in California and other Democrat-led states over potential misuse in immigrant healthcare programs.
LOCALIZE IT: Many states have protections from utility shutoffs in extreme heat. Does yours?
NEW YORK (AP) — EDITORS/NEWS DIRECTORS:
The Hidden Silver Stock With $264 Million in Quarterly Revenue - Ad
A founder who built First Quantum Minerals now leads this producer. Four mines, rising output, and no hedges. His conviction is baked into every ounce.
Artelo Biosciences Drug Helps Cancer Patients Regain Weight, Eyes Licensing Deal
Artelo Biosciences reported encouraging Phase 2 trial results for ART27.13 in cancer anorexia-cachexia syndrome, citing strong partner interest.
Trump Admin 'Lying' And 'Fudging The Numbers' About Social Security Wait-Time Data, Says Elizabeth Warren
Senator Warren accuses Trump administration of lying about Social Security wait times and calls for an investigation instead of 'fudging the numbers'.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
Robert Kennedy Jr.'s Leadership Can Only Bring More 'Harm,' Says Top Ex-CDC Official: 'Undoing Of Vaccination' In Works
Daskalakis resigned due to political interference in CDC, fears harm will come from new direction. CDC leaders also resign in protest.
Social Security whistleblower who claims DOGE mishandled Americans' sensitive data resigns from post
WASHINGTON (AP) — A Social Security official who has filed a whistleblower complaint alleging the Department of Government Efficiency officials Americans' sensitive information says he's resigning his post because of actions taken against him since making his complaint.
We've Seen This Before... and It Didn't End Well - Ad
Strange events are unfolding in the global financial system. A monetary reset dubbed the "Mar-a-Lago Accord" is quietly in motion, and the financial elite are already taking protective action. If history is any guide, you could lose up to 40% of your wealth in the next two years. Move your money before it's too late.
Stock Of The Day: Time To Buy Cooper Companies?
The Cooper Companies (COO) are oversold and at support. These dynamics can set the stage for a new uptrend to form.
Johnson & Johnson Ends Rheumatoid Arthritis Drug Combo Program
Johnson & Johnson ended a Phase 2a study of nipocalimab in rheumatoid arthritis after no added benefit was seen, but remains confident in its market potential.
Discover 3 Stocks Projected to Dethrone Nvidia (NVDA) - Ad
Futurist and Stock Analyst, Eric Fry, published a brand-new research report naming three outsider stocks have the power to completely disrupt the "seemingly invincible" Mag 7. For the time being, this research report is available through this page - at no charge.
Stock Of The Day: Another Breakout For Eli Lilly?
Shares of Eli Lilly (LLY) are testing a resistance level. If they can break through this resistance, a large more higher may follow.
UK Patients Scramble For Mounjaro As Eli Lilly's 170% Price Hike Plan Sparks Shortages, Health Fears
Patients in UK struggle to obtain Mounjaro drug due to high demand, sharp price increase. Shortages causing stress and health risks.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.